Author: Greg Winterton
The UK’s equity release securitisation market has re-emerged in recent years as a tool in a life insurer’s capital optimisation effort.
Greg Winterton caught up with Dr. Joshua Funder, CEO and Managing Director of Household Capital, to discuss the current state of and outlook for the reverse mortgage sector of the Australian securitisation market in this month’s Q&A.
One of the findings from the 2025 ELSA–Conning Life Settlement Investor Sentiment Study was that investors see life settlements sitting in their ‘resilience bucket,’ alongside private credit, infrastructure, and real assets.
There is plenty of investment work still to do even for those US plan sponsors that are in the last mile of their buy-out journey.
Actuarial Guideline 55 is designed to provide regulators with more transparency into the asset adequacy of offshore asset-intensive life reinsurance structures.
The UK’s pension risk transfer market posted another strong year in 2025 both in terms of activity and aggregate premium transacted. Greg Winterton caught up with Alan Greenlees, Professional Trustee and Head of Risk Transfer at ZEDRA, to get his insights on a range of sub-topics within the space as 2026 begins in this month’s Q&A.
December saw a few developments in the PHL Variable Life Insurance Company rehabilitation story but a liquidation means much more is to come.
US reverse mortgage market awaits next steps in plan to reform HECM and HMBS programs.
Moritz Roever of Vitaro Group provides his thoughts on how the servicing function in life settlement portfolios can be additive to alpha generation.
Two new reports from insurance asset manager Conning – one of them produced in conjunction with life settlement industry group the European Life Settlement Association (ELSA), publisher of Longevity and Mortality Investor – paint an optimistic picture of the state of the life settlement market.